% Expired Patents = 50.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 32

Loading Chart...

10 inventors (with patents filed for the assignee):

Young Chul Sung (4 out of 25 patents)

Sang Jun Ha (2 out of 2 patents)

Man Ki Song (2 out of 2 patents)

4. Jun Chang (2 out of 2 patents)

5. Sung Hee Lee (2 out of 27 patents)

6. Sang Hwan Seo (1 out of 4 patents)

7. Sehwan Yang (1 out of 5 patents)

8. Hyun Tak Jin (1 out of 2 patents)

9. Je-In Youn (1 out of 2 patents)

10. Sang Hoon Park (1 out of 4 patents)

4 patents: Sort by Forward Citations

1. 8137674 - Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer (2012-03-20),

2. 7910564 - Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant (2011-03-22),

3. 7867491 - Immunoglobulin fusion proteins (2011-01-11),

4. 7253151 - Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant (2007-08-07),

Company Overview

Genexine is a leading biotechnology company specializing in the development of innovative biopharmaceuticals for the treatment of various diseases. With a strong focus on research and development, Genexine is committed to delivering cutting-edge therapies that make a real difference in patients' lives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#768 in Seoul

#2,202 in South Korea

Seoul, South Korea

Genexine Co., Ltd.

Forward Citations = 32

10 inventors:

Young Chul Sung (4 out of 25 patents)

Sang Jun Ha (2 out of 2 patents)

Man Ki Song (2 out of 2 patents)

4. Jun Chang (2 out of 2 patents)

5. Sung Hee Lee (2 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genexine Co., Ltd.. Retrieved from https://idiyas.com/company/genexine-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]